Topic

Director, eCOA Solutions Engineering, IQVIA

Articles

Industry now leveraging reporting system to empower patients and improve research.

   ePROs in Oncology: Breaking Through Barriers for Better Drug Development and Higher Quality Care

Sirj Goswami, PhD, CEO, co-founder of InsightRX

Vice president of Global Biopharma Strategy

Understanding Project Optimus

Pandemic has brought new sense of awareness to respiratory diseases and clinops.

How COVID is Forcing a Reckoning in Respiratory Clinical Trials

Executive Director of Clinical Science, Regor Pharmaceuticals, Inc.

Guidance will compel sponsors to consider new enrollment strategies and to be more diverse. 

FDA’s New Diversity Plan Guidance, And What It Means for Sponsors Developing Cancer Drugs

By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers.

Real-World Data Offers Significant Opportunities for Developing New Therapies for Hematologic Cancers

Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.

A Digital Twin on KRAS G12C NSCLC Patients with SCA Measured by PFS

Porter discusses regulatory compliance, ATMP sponsors, and Philadelphia’s Cellicon Valley.

Q&A With Jennifer Porter, partner, Troutman Pepper

Director of Clinical Research, Winterlight Labs

Future shows great potential for neurological language assessments in clinical trials.

How Speech-Based Digital Biomarkers are Redefining the Measurement of Disease Progression in Neurodegenerative Dementia Trials

Successful oncolytic virus immunotherapy clinical development requires unique features that focus on viral biology and host immune response.

Oncolytic Virus Immunotherapy: A Brief Overview and Considerations for Clinical Trial Planning 

Steps that investigators and sponsors can take to streamline trials and accelerate the time to market for lifesaving therapies.

Therapeutic Areas